CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry.

Dedicated to improving the quality of life for patients throughout the world, CSL Behring provides safe and effective plasma-derived and recombinant products and offers patients a wide range of related services.

The company's broad portfolio of life-saving therapeutics are used in the treatment of individuals with haemophilia and other bleeding disorders, immune deficiency disorders and inherited emphysema; the prevention of haemolytic diseases for the newborn; cardiac surgery patients; and shock and burn victims.

Additionally, CSL Behring operates one of the world's largest, fully owned plasma collection networks. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company, which operates worldwide from its headquarters in Melbourne, Australia.

For more information about the company, please visit  CSL Behring